New Triple-Drug combo aims to wipe out Hard-to-Treat leukemia
Disease control
Recruiting now
This study tests whether adding a new drug called roginolisib to two standard drugs (venetoclax and rituximab) is safe and works better for people with chronic lymphocytic leukemia (CLL) that has come back or not responded to prior treatments. About 64 adults who have already tri…
Phase: PHASE1, PHASE2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated May 17, 2026 09:09 UTC